RxDoctor Payments DataLook up a doctor →

Richard Johnston, MD

Gastroenterology · Columbus, MSNPI 1790717478

Payments from drug & device makers

$8,267in general payments, 2019–2025

Across 496 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$716
  • Sanofi$676
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$620
  • Gilead$424
  • plus $3K from 23 others

What the payments were for

  • Food & beverage$8,05897%
  • Education$2083%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,267 in reported general payments places this provider in the 60th percentile of 127 gastroenterology providers in Mississippi.

See all gastroenterology providers in Mississippi

Medicare billing

Part B allowed, 2024
$321,489
Medicare patients
555
Services billed
6,425

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab15$213,909
ZenpepLipase/Protease/Amylase32$183,892
LinzessLinaclotide130$115,655
IbsrelaTenapanor Hcl17$36,355
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates169$11,304
Dexlansoprazole DrDexlansoprazole34$7,864
Pantoprazole Sodium614$5,122
Colestipol Hcl57$5,079
DexilantDexlansoprazole12$3,616
Lubiprostone11$2,916
Ursodiol20$2,462
Sucralfate63$2,319
Famotidine272$2,276
Omeprazole245$2,117
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl86$1,239

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Aimmune Therapeutics, Inc.Zenpep$194$183,89232 claims
AbbVieLinzess$1,844$115,655130 claims
Ardelyx, Inc.Ibsrela$354$36,35517 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$716$3,61612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 127 gastroenterology providers in Mississippi.

Other gastroenterology in Columbus

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →